Open | $7.790 |
Close | $7.960 |
Volume / Avg. | 3.552M / 2.559M |
Day Range | 7.390 - 8.310 |
52 Wk Range | 4.520 - 16.620 |
Market Cap | $1.053B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 5.63% |
Days to Cover | 2.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Maravai LifeSciences (NASDAQ: MRVI) through any online brokerage.
Other companies in Maravai LifeSciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).
The latest price target for Maravai LifeSciences (NASDAQ: MRVI) was reported by RBC Capital on Friday, February 23, 2024. The analyst firm set a price target for 14.00 expecting MRVI to rise to within 12 months (a possible 75.88% upside). 19 analyst firms have reported ratings in the last year.
The stock price for Maravai LifeSciences (NASDAQ: MRVI) is $7.96 last updated March 18, 2024 at 6:35 PM EDT.
There are no upcoming dividends for Maravai LifeSciences.
Maravai LifeSciences’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Maravai LifeSciences.
Maravai LifeSciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.